Pendal Group Ltd lifted its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 3.3% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 332,646 shares of the medical research company’s stock after purchasing an additional 10,526 shares during the quarter. Thermo Fisher Scientific comprises about 1.2% of Pendal Group Ltd’s holdings, making the stock its 21st biggest holding. Pendal Group Ltd’s holdings in Thermo Fisher Scientific were worth $85,957,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also modified their holdings of the company. Truvestments Capital LLC purchased a new stake in shares of Thermo Fisher Scientific during the first quarter worth approximately $29,000. Capital Advisors Ltd. LLC increased its stake in Thermo Fisher Scientific by 250.0% in the second quarter. Capital Advisors Ltd. LLC now owns 140 shares of the medical research company’s stock valued at $41,000 after purchasing an additional 100 shares during the last quarter. Focused Wealth Management Inc purchased a new position in Thermo Fisher Scientific in the second quarter valued at approximately $44,000. Farmers & Merchants Trust Co of Chambersburg PA increased its stake in Thermo Fisher Scientific by 168.0% in the first quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 201 shares of the medical research company’s stock valued at $55,000 after purchasing an additional 126 shares during the last quarter. Finally, Cullen Frost Bankers Inc. purchased a new position in Thermo Fisher Scientific in the first quarter valued at approximately $64,000. 88.21% of the stock is currently owned by institutional investors and hedge funds.
TMO stock traded up $3.56 during mid-day trading on Tuesday, hitting $275.56. The stock had a trading volume of 85,588 shares, compared to its average volume of 1,615,221. The company has a quick ratio of 1.07, a current ratio of 1.49 and a debt-to-equity ratio of 0.58. Thermo Fisher Scientific Inc. has a 1-year low of $208.34 and a 1-year high of $305.45. The business’s fifty day moving average price is $288.55. The stock has a market cap of $110.68 billion, a PE ratio of 24.77, a price-to-earnings-growth ratio of 1.81 and a beta of 1.11.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 15th. Stockholders of record on Tuesday, September 17th will be issued a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.28%. The ex-dividend date is Monday, September 16th. Thermo Fisher Scientific’s dividend payout ratio is 6.83%.
A number of brokerages have recently issued reports on TMO. Credit Suisse Group restated a “buy” rating and set a $310.00 target price on shares of Thermo Fisher Scientific in a research report on Wednesday, July 31st. Argus upped their target price on Thermo Fisher Scientific from $285.00 to $310.00 and gave the stock a “buy” rating in a research report on Wednesday, May 1st. Bank of America reaffirmed a “buy” rating and issued a $300.00 target price (up from $285.00) on shares of Thermo Fisher Scientific in a research report on Tuesday, April 16th. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $299.00 target price on the stock in a research report on Wednesday, June 12th. Finally, Needham & Company LLC upped their target price on Thermo Fisher Scientific from $315.00 to $321.00 and gave the stock a “buy” rating in a research report on Thursday, July 25th. Two analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $303.17.
In other news, CEO Marc N. Casper sold 50,000 shares of the stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $284.83, for a total transaction of $14,241,500.00. Following the transaction, the chief executive officer now owns 342,193 shares of the company’s stock, valued at approximately $97,466,832.19. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director C Martin Harris sold 275 shares of the stock in a transaction dated Wednesday, June 5th. The shares were sold at an average price of $270.73, for a total value of $74,450.75. Following the transaction, the director now directly owns 6,433 shares in the company, valued at approximately $1,741,606.09. The disclosure for this sale can be found here. In the last three months, insiders have sold 52,775 shares of company stock worth $14,986,676. 0.45% of the stock is currently owned by insiders.
Thermo Fisher Scientific Profile
Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.
Featured Article: Are sell-side analysts objective?
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.